↓ Skip to main content

Dove Medical Press

Article Metrics

What is this page? Embed badge

Axicabtagene ciloleucel (KTE-C19), an anti-CD19 CAR T therapy for the treatment of relapsed/refractory aggressive B-cell non-Hodgkin’s lymphoma

Overview of attention for article published in Therapeutics and Clinical Risk Management, May 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (71st percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

policy
1 policy source
twitter
1 X user
patent
1 patent

Citations

dimensions_citation
45 Dimensions

Readers on

mendeley
117 Mendeley
Summary Policy documents X Patents Dimensions citations
So far, Dimensions has found 45 publications that cite this research output.

45

The most recent citing publications are shown below. View all 45 publications that cite this research output on Dimensions.

This page is hosted by Altmetric on behalf of Dove Medical Press.